Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-8bljj Total loading time: 0 Render date: 2024-07-07T22:57:53.224Z Has data issue: false hasContentIssue false

2 - Pathology of adult renal parenchymal cancers

Published online by Cambridge University Press:  08 August 2009

By
Patricia Harnden
Edited by
Uday Patel
Patricia Harnden
Affiliation:
Consultant, Urological Pathologist, Cancer Research, UK Clinical Centre, St James's University Hospital, Leeds, UK
Uday Patel
Affiliation:
St George's Hospital, London
Get access

Summary

Introduction

There have been a number of recent advances in our understanding of the pathology of renal cancer. This has not only resulted in some re-classification of cancer types but also improved our ability to pathologically characterize tumors allowing improved prognostication. All these aspects are reviewed here. Additionally the role of modern immunohistochemistry in the characterization of tumors from samples obtained by image-guided core biopsy is discussed.

Pathological classification of malignant renal tumors

Previous classifications

Previous classifications of renal tumors were based on their morphology, resulting in numerous subtypes and practical difficulties because of overlapping appearances. Subsequently, greater understanding of the genetic alterations underlying different subtypes and their morphological correlates led to a simplified and more relevant classification – the Heidelberg consensus classification. Whereas the original World Health Organization (WHO) classification separated clear cell from granular cell renal carcinomas, cytogenetic analyses revealed that these were different manifestations of the same abnormality involving the von Hippel–Lindau (VHL) gene on the short arm of chromosome 3, giving rise to the most common type of renal carcinoma. These “conventional” carcinomas have variable proportions of clear or granular cells (Figure 2.1) depending on the cytoplasmic content of fat (which “clears” during histological processing) or mitochondria (responsible for the granular or oncocytic appearance of cells). Spindle cell or sarcomatoid change has long been recognized as an indication of poor differentiation rather than an indication of cell lineage, and tumors within the WHO spindle cell category could often be classified by cytogenetic analysis.

Type
Chapter
Information
Carcinoma of the Kidney , pp. 17 - 37
Publisher: Cambridge University Press
Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Mostofi, F. K., and Davis, C. J., Histological Typing of Kidney Tumours, 2nd edn (Berlin, Heidelberg, New York: Springer, 1998).CrossRefGoogle Scholar
Kovacs, G., Akhtar, M., Beckwith, B. J.et al., The Heidelberg classification of renal cell tumours. J Pathol, 183 (1997), 131–3.3.0.CO;2-G>CrossRefGoogle ScholarPubMed
Storkel, S., Eble, J. N., Adlakha, K.et al., Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer, 80 (1997), 987–9.3.0.CO;2-R>CrossRefGoogle Scholar
Fuhrman, S. A., Lasky, L. C., and Limas, C., Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol, 6 (1982), 655–63.CrossRefGoogle ScholarPubMed
Eble, J., Sauter, G., Epstein, J.et al., Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs (Lyon: IARC Press, 2004).Google Scholar
Gudbjartsson, T., Hardarson, S., Petursdottir, V.et al., Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients. Eur Urol, 48 (2005), 593–600.CrossRefGoogle ScholarPubMed
Cheville, J. C., Lohse, C. M., Zincke, H.et al., Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol, 27 (2003), 612–24.CrossRefGoogle ScholarPubMed
Moch, H., Gasser, T., Amin, M. B.et al., Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer, 89 (2000), 604–14.3.0.CO;2-Q>CrossRefGoogle ScholarPubMed
Patard, J. J., Leray, E., Rioux-Leclercq, N.et al., Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol, 23 (2005), 2763–71.CrossRefGoogle ScholarPubMed
Bell, E. T., Renal Diseases (Philadelphia: Lea & Febiger, 1950).Google Scholar
Eschwege, P., Saussine, C., Steichen, G.et al., Radical nephrectomy for renal cell carcinoma 30 mm. or less: long-term follow results. J Urol, 155 (1996), 1196–9.CrossRefGoogle ScholarPubMed
Reis, M., Faria, V., Lindoro, J.et al., The small cystic and noncystic noninflammatory renal nodules: a postmortem study. J Urol, 140 (1988), 721–4.CrossRefGoogle ScholarPubMed
Xipell, J. M., The incidence of benign renal nodules (a clinicopathologic study). J Urol, 106 (1971), 503–6.CrossRefGoogle Scholar
Kovacs, G., Fuzesi, L., Emanual, A.et al., Cytogenetics of papillary renal cell tumors. Genes Chromosomes Cancer, 3 (1991), 249–55.CrossRefGoogle ScholarPubMed
Barocas, D. A., Mathew, S., DelPizzo, J. J.et al., Renal cell carcinoma sub-typing by histopathology and fluorescence in situ hybridization on a needle-biopsy specimen. BJU Int, 99 (2007), 290–5.CrossRefGoogle ScholarPubMed
Abrahams, N. A., MacLennan, G. T., Khoury, J. D.et al., Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray. Histopathology, 45 (2004), 593–602.CrossRefGoogle ScholarPubMed
Kuroda, N., Toi, M., Yamamoto, M.et al., Immunohistochemical identification of intracytoplasmic lumens by cytokeratin typing may differentiate renal oncocytomas from chromophobe renal cell carcinomas. Histol Histopathol, 19 (2004), 23–8.Google ScholarPubMed
Wang, H. Y. and Mills, S. E., KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of clear cell renal cell carcinoma. Am J Surg Pathol, 29 (2005), 640–6.CrossRefGoogle ScholarPubMed
Mazal, P. R., Stichenwirth, M., Koller, A.et al., Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: a tissue microarray study. Mod Pathol, 18 (2005), 535–40.CrossRefGoogle ScholarPubMed
Shen, S. S., Krishna, B., Chirala, R.et al., Kidney-specific cadherin, a specific marker for the distal portion of the nephron and related renal neoplasms. Mod Pathol, 18 (2005), 933–40.CrossRefGoogle ScholarPubMed
Langner, C., Wegscheider, B. J., Ratschek, M.et al., Keratin immunohistochemistry in renal cell carcinoma subtypes and renal oncocytomas: a systematic analysis of 233 tumors. Virchows Arch, 444 (2004), 127–34.CrossRefGoogle ScholarPubMed
Rampino, T., Gregorini, M., Soccio, G.et al., The Ron proto-oncogene product is a phenotypic marker of renal oncocytoma. Am J Surg Pathol, 27 (2003), 779–85.CrossRefGoogle ScholarPubMed
Patton, K. T., Tretiakova, M. S., Yao, J. L.et al., Expression of RON Proto-oncogene in Renal Oncocytoma and Chromophobe Renal Cell Carcinoma. Am J Surg Pathol, 28 (2004), 1045–50.CrossRefGoogle ScholarPubMed
Mazal, P. R., Exner, M., Haitel, A.et al., Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma. Hum Pathol, 36 (2005), 22–8.CrossRefGoogle ScholarPubMed
Adley, B. P., Gupta, A., Lin, F.et al., Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma. Am J Clin Pathol, 126 (2006), 79–85.CrossRefGoogle ScholarPubMed
Banks, R. E., Craven, R. A., Harnden, P. A.et al., Use of a sensitive EnVision +-based detection system for Western blotting: avoidance of streptavidin binding to endogenous biotin and biotin-containing proteins in kidney and other tissues. Proteomics, 3 (2003), 558–61.CrossRefGoogle ScholarPubMed
Southgate, J., Harnden, P., and Holt, J., Which proliferation markers for routine immunohistology?J Clin Pathol, 49 (1996), 270.CrossRefGoogle ScholarPubMed
Adley, B. P., Papavero, V., Sugimura, J.et al., Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma. Anal Quant Cytol Histol, 28 (2006), 228–36.Google ScholarPubMed
Chu, P. G. and Weiss, L. M., Cytokeratin 14 immunoreactivity distinguishes oncocytic tumour from its renal mimics: an immunohistochemical study of 63 cases. Histopathology, 39 (2001), 455–62.CrossRefGoogle ScholarPubMed
Mete, O., Kilicaslan, I., Gulluoglu, M. G.et al., Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis. Virchows Arch, 447 (2005), 938–46.CrossRefGoogle ScholarPubMed
Robson, C. J., Churchill, B. M., and Anderson, W., The results of radical nephrectomy for renal cell carcinoma. J Urol, 101 (1969), 297–301.CrossRefGoogle ScholarPubMed
Guinan, P., Sobin, L. H., Algaba, F.et al., TNM staging of renal cell carcinoma: Workgroup No. 3. Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer, 80 (1997), 992–3.3.0.CO;2-Q>CrossRefGoogle Scholar
Gospodarowicz, M. K., Miller, D., Groome, P. A.et al., The process for continuous improvement of the TNM classification. Cancer, 100:1 (2004), 1–5.CrossRefGoogle ScholarPubMed
Sobin, L. H. and Wittekind, C., TNM Classification of Malignant Tumours, 5th edn (New York: John Wiley, 1997).Google Scholar
Sobin, L. H. and Wittekind, C., TNM Classification of Malignant Tumours, 6th edn (New York: Wiley-Liss, 2002).Google Scholar
Minervini, R., Minervini, A., Fontana, N.et al., Evaluation of the 1997 tumour, nodes and metastases classification of renal cell carcinoma: experience in 172 patients. BJU Int, 86 (2000), 199–202.CrossRefGoogle ScholarPubMed
Delahunt, B., Kittelson, J. M., McCredie, M. R.et al., Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma: assessment of TNM T1 and T2 tumor categories and comparison with other prognostic parameters. Cancer, 94 (2002), 658–64.CrossRefGoogle ScholarPubMed
Lau, W. K., Cheville, J. C., Blute, M. L.et al., Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy. Urology, 59 (2002), 532–7.CrossRefGoogle ScholarPubMed
Kuczyk, M., Wegener, G., Merseburger, A. S.et al., Impact of tumor size on the long-term survival of patients with early stage renal cell cancer. World J Urol, 23 (2005), 50–4.CrossRefGoogle ScholarPubMed
Frank, I., Blute, M. L., Cheville, J. C.et al., An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol, 168 (2002), 2395–400.CrossRefGoogle ScholarPubMed
Frank, I., Blute, M. L., Leibovich, B. C.et al., pT2 classification for renal cell carcinoma. Can its accuracy be improved?J Urol, 173 (2005), 380–4.CrossRefGoogle ScholarPubMed
Silverio, F. Di, Casale, P., Colella, D.et al., Independent value of tumor size and DNA ploidy for the prediction of disease progression in patients with organ-confined renal cell carcinoma. Cancer, 88 (2000), 835–43.3.0.CO;2-J>CrossRefGoogle ScholarPubMed
Leibovich, B. C., Blute, M. L., Cheville, J. C.et al., Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer, 97 (2003), 1663–71.CrossRefGoogle ScholarPubMed
Sorbellini, M., Kattan, M. W., Snyder, M. E.et al., A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol, 173 (2005), 48–51.CrossRefGoogle ScholarPubMed
Guinan, P. D., Vogelzang, N. J., Fremgen, A. M.et al., Renal cell carcinoma: tumor size, stage and survival. Members of the Cancer Incidence and End Results Committee. J Urol, 153 (1995), 901–3.CrossRefGoogle ScholarPubMed
Amin, M. B., Amin, M. B., Tamboli, P.et al., Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol, 26 (2002), 281–91.CrossRefGoogle ScholarPubMed
Ficarra, V., Righetti, R., Pilloni, S.et al., Prognostic factors in patients with renal cell carcinoma: retrospective analysis of 675 cases. Eur Urol, 41 (2002), 190–8.CrossRefGoogle ScholarPubMed
Cheville, J. C., Lohse, C. M., Zincke, H.et al., Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol, 28 (2004), 435–41.CrossRefGoogle ScholarPubMed
Leibovich, B. C., Han, K. R., Bui, M. H.et al., Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer, 98 (2003), 2566–75.CrossRefGoogle ScholarPubMed
Ficarra, V., Martignoni, G., Lohse, C.et al., External validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) score to predict cancer specific survival using a European series of conventional renal cell carcinoma. J Urol, 175 (2006), 1235–9.CrossRefGoogle Scholar
Zisman, A., Chao, D. H., Pantuck, A. J.et al., Unclassified renal cell carcinoma: clinical features and prognostic impact of a new histological subtype. J Urol, 168 (2002), 950–5.CrossRefGoogle ScholarPubMed
Tokuda, N., Naito, S., Matsuzaki, O.et al., Collecting duct (Bellini duct) renal cell carcinoma: a nationwide survey in Japan. J Urol, 176 (2006), 40–3; discussion 43.CrossRefGoogle ScholarPubMed
Suzigan, S., Lopez-Beltran, A., Montironi, R.et al., Multilocular cystic renal cell carcinoma: a report of 45 cases of a kidney tumor of low malignant potential. Am J Clin Pathol, 125 (2006), 217–22.CrossRefGoogle ScholarPubMed
Lee, S. E., Byun, S. S., Oh, J. K.et al., Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma. J Urol, 176 (2006), 1332–7.CrossRefGoogle ScholarPubMed
Sengupta, S., Lohse, C. M., Leibovich, B. C.et al., Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness. Cancer, 104 (2005), 511–20.CrossRefGoogle ScholarPubMed
Lam, J. S., Shvarts, O., Said, J. W.et al., Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma. Cancer, 103 (2005), 2517–25.CrossRefGoogle ScholarPubMed
Frank, I., Blute, M. L., Cheville, J. C.et al., A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma. J Urol, 170 (2003), 2225–32.CrossRefGoogle ScholarPubMed
Sabo, E., Boltenko, A., Sova, Y.et al., Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma. Clin Cancer Res, 7 (2001), 533–7.Google ScholarPubMed
Goncalves, P. D., Srougi, M., Dall, M. F.'lio et al., Low clinical stage renal cell carcinoma: relevance of microvascular tumor invasion as a prognostic parameter. J Urol, 172 (2004), 470–4.CrossRefGoogle ScholarPubMed
Griffiths, D. F., Verghese, A., Golash, A.et al., Contribution of grade, vascular invasion and age to outcome in clinically localized renal cell carcinoma. BJU Int, 90 (2002), 26–31.CrossRefGoogle ScholarPubMed
Sevinc, M., Kirkali, Z., Yorukoglu, K.et al., Prognostic significance of microvascular invasion in localized renal cell carcinoma. Eur Urol, 38 (2000), 728–33.Google ScholarPubMed
Palapattu, G. S., Pantuck, A. J., Dorey, F.et al., Collecting system invasion in renal cell carcinoma: impact on prognosis and future staging strategies. J Urol, 170 (2003), 768–72.CrossRefGoogle ScholarPubMed
Terrone, C., Cracco, C., Guercio, S.et al., Prognostic value of the involvement of the urinary collecting system in renal cell carcinoma. Eur Urol, 46 (2004), 472–6.CrossRefGoogle ScholarPubMed
Uzzo, R. G., Cherullo, E. E., Myles, J.et al., Renal cell carcinoma invading the urinary collecting system: implications for staging. J Urol, 167 (2002), 2392–6.CrossRefGoogle ScholarPubMed
Zisman, A., Pantuck, A. J., Wieder, J.et al., Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol, 20 (2002), 4559–66.CrossRefGoogle ScholarPubMed
Ficarra, V., Prayer-Galetti, T., Novella, G.et al., Incidental detection beyond pathological factors as prognostic predictor of renal cell carcinoma. Eur Urol, 43 (2003), 663–9.CrossRefGoogle ScholarPubMed
Lee, C. T., Katz, J., Fearn, P. A.et al., Mode of presentation of renal cell carcinoma provides prognostic information. Urol Oncol, 7 (2002), 135–40.CrossRefGoogle ScholarPubMed
Patard, J. J., Rodriguez, A., Rioux-Leclercq, N.et al., Prognostic significance of the mode of detection in renal tumours. BJU Int, 90 (2002), 358–63.CrossRefGoogle ScholarPubMed
Gudbjartsson, T., Thoroddsen, A., Petursdottir, V.et al., Effect of incidental detection for survival of patients with renal cell carcinoma: results of population-based study of 701 patients. Urology, 66 (2005), 1186–91.CrossRefGoogle ScholarPubMed
McShane, L. M., Altman, D. G., and Sauerbrei, W.. Identification of clinically useful cancer prognostic factors: what are we missing?J Natl Cancer Inst, 97:14 (2005), 1023–5.CrossRefGoogle ScholarPubMed
McShane, L. M., Altman, D. G., Sauerbrei, W.et al., Reporting recommendations for tumor marker prognostic studies. J Clin Oncol, 23 (2005), 9067–72.CrossRefGoogle ScholarPubMed
Wykoff, C. C., Beasley, N. J., Watson, P. H.et al., Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res, 60 (2000), 7075–83.Google ScholarPubMed
Bui, M. H., Seligson, D., Han, K. R.et al., Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin Cancer Res, 9 (2003), 802–11.Google ScholarPubMed
Atkins, M., Regan, M., McDermott, D.et al., Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer. Clin Cancer Res, 11 (2005), 3714–21.CrossRefGoogle ScholarPubMed
Brouwers, A. H., Dorr, U., Lang, O.et al., 131 I-cG250 monoclonal antibody immunoscintigraphy versus [18 F]FDG-PET imaging in patients with metastatic renal cell carcinoma: a comparative study. Nucl Med Commun, 23 (2002), 229–36.CrossRefGoogle ScholarPubMed
Bleumer, I., Oosterwijk, E., Oosterwijk-Wakka, J. C.et al., A clinical trial with chimeric monoclonal antibody WX-G250 and low dose interleukin-2 pulsing scheme for advanced renal cell carcinoma. J Urol, 175 (2006), 57–62.CrossRefGoogle ScholarPubMed
Torp-Pedersen, S., Juul, N., Larsen, T.et al., US-guided fine needle biopsy of solid renal masses – comparison of histology and cytology. Scand J Urol Nephrol Suppl, 137 (1991), 41–3.Google ScholarPubMed
Bracken, R. B., Chica, G., Johnson, D. E.et al., Secondary renal neoplasms: an autopsy study. South Med J, 72 (1979), 806–7.CrossRefGoogle Scholar
Rybicki, F. J., Shu, K. M., Cibas, E. S.et al., Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses. AJR Am J Roentgenol, 180 (2003), 1281–7.CrossRefGoogle ScholarPubMed
Snyder, M. E., Bach, A., Kattan, M. W.et al., Incidence of benign lesions for clinically localized renal masses smaller than 7 cm in radiological diameter: influence of sex. J Urol, 176 (2006), 2391–5.CrossRefGoogle Scholar
Schlomer, B., Figenshau, R. S., Yan, Y.et al., Pathological features of renal neoplasms classified by size and symptomatology. J Urol, 176:4 (Pt 1) (2006), 1317–20; discussion 1320.CrossRefGoogle ScholarPubMed
Saxena, A., Alport, E. C., Custead, S.et al., Molecular analysis of clonality of sporadic angiomyolipoma. J Pathol, 189 (1999), 79–84.3.0.CO;2-C>CrossRefGoogle ScholarPubMed
L'Hostis, H., Deminiere, C., Ferriere, J. M.et al., Renal angiomyolipoma: a clinicopathologic, immunohistochemical, and follow-up study of 46 cases. Am J Surg Pathol, 23 (1999), 1011–20.CrossRefGoogle ScholarPubMed
Tallarigo, C., Baldassarre, R., Bianchi, G.et al., Diagnostic and therapeutic problems in multicentric renal angiomyolipoma. J Urol, 148 (1992), 1880–4.CrossRefGoogle ScholarPubMed
Daniel, L., Barriol, D., Lechevallier, E.et al., Diagnostic value of percutaneous biopsy of the renal masses. 73 cases. Ann Pathol, 20 (2000), 119–23.Google ScholarPubMed
Neuzillet, Y., Lechevallier, E., Andre, M.et al., Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses. J Urol, 171 (2004), 1802–5.CrossRefGoogle ScholarPubMed
Davis, C. J., Barton, J. H., and Sesterhenn, I. A., Cystic angiomyolipoma of the kidney: a clinicopathologic description of 11 cases. Mod Pathol, 19 (2006), 669–74.CrossRefGoogle ScholarPubMed
Lang, E. K., Macchia, R. J., Gayle, B.et al., CT-guided biopsy of indeterminate renal cystic masses (Bosniak 3 and 2F): accuracy and impact on clinical management. Eur Radiol, 12 (2002), 2518–24.CrossRefGoogle ScholarPubMed
Drucker, B. J., Renal cell carcinoma: current status and future prospects. Cancer Treat Rev, 31 (2005), 536–45.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Pathology of adult renal parenchymal cancers
    • By Patricia Harnden, Consultant, Urological Pathologist, Cancer Research, UK Clinical Centre, St James's University Hospital, Leeds, UK
  • Edited by Uday Patel, St George's Hospital, London
  • Book: Carcinoma of the Kidney
  • Online publication: 08 August 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545436.004
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Pathology of adult renal parenchymal cancers
    • By Patricia Harnden, Consultant, Urological Pathologist, Cancer Research, UK Clinical Centre, St James's University Hospital, Leeds, UK
  • Edited by Uday Patel, St George's Hospital, London
  • Book: Carcinoma of the Kidney
  • Online publication: 08 August 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545436.004
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Pathology of adult renal parenchymal cancers
    • By Patricia Harnden, Consultant, Urological Pathologist, Cancer Research, UK Clinical Centre, St James's University Hospital, Leeds, UK
  • Edited by Uday Patel, St George's Hospital, London
  • Book: Carcinoma of the Kidney
  • Online publication: 08 August 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511545436.004
Available formats
×